Actively Recruiting

Phase 1
Phase 2
Age: 18Years +
All Genders
NCT06596694

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

Led by Merck Sharp & Dohme LLC · Updated on 2026-04-23

180

Participants Needed

62

Research Sites

213 weeks

Total Duration

On this page

Sponsors

M

Merck Sharp & Dohme LLC

Lead Sponsor

D

Daiichi Sankyo

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers want to learn if patritumab deruxtecan (MK-1022) can treat certain gastrointestinal (GI) cancers. The GI cancers being studied are advanced (the cancer has spread to other parts of the body). The goals of this study are to learn: * About the safety and how well people tolerate of patritumab deruxtecan * How many people have the cancer respond (get smaller or go away) to treatment

CONDITIONS

Official Title

Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Has unresectable or metastatic colorectal cancer
  • Has advanced and/or unresectable biliary tract cancer
  • Has hepatocellular carcinoma not amenable to locoregional therapy
  • Has locally advanced unresectable or metastatic gastroesophageal cancer
  • Has received prior therapy for the cancer
  • Has recovered from side effects of previous cancer treatment
Not Eligible

You will not qualify if you...

  • History of noninfectious interstitial lung disease or pneumonitis requiring steroids
  • Current or suspected interstitial lung disease or pneumonitis not ruled out
  • Clinically severe respiratory compromise from lung illnesses
  • Evidence of leptomeningeal disease
  • Clinically significant corneal disease
  • Uncontrolled significant cardiovascular or cerebrovascular disease
  • Ongoing uncontrolled systemic bacterial, fungal, or viral infection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 62 locations

1

UCLA Hematology Oncology Santa Monica ( Site 1205)

Santa Monica, California, United States, 90404

Actively Recruiting

2

University of Colorado Cancer Center ( Site 1200)

Aurora, Colorado, United States, 80045

Actively Recruiting

3

Sibley Memorial Hospital ( Site 1208)

Washington D.C., District of Columbia, United States, 20016

Actively Recruiting

4

University of Florida ( Site 1202)

Gainesville, Florida, United States, 32610

Actively Recruiting

5

Mount Sinai Medical Center Comprehensive Cancer Center ( Site 1213)

Miami Beach, Florida, United States, 33140

Actively Recruiting

6

Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital-Research ( Site 1203)

Marietta, Georgia, United States, 30060

Completed

7

University of Chicago Medical Center ( Site 1204)

Chicago, Illinois, United States, 60637

Actively Recruiting

8

Renown Regional Medical Center ( Site 1221)

Reno, Nevada, United States, 89502

Actively Recruiting

9

NYU Langone Hospital - Long Island ( Site 1230)

Mineola, New York, United States, 11501

Actively Recruiting

10

Perlmutter NYU Cancer Center ( Site 1212)

New York, New York, United States, 10016

Actively Recruiting

11

Scott & White Medical Center-Temple ( Site 1224)

Temple, Texas, United States, 76508

Actively Recruiting

12

Oncology and Hematology Associates of Southwest Virginia (BRCC) ( Site 1207)

Roanoke, Virginia, United States, 24014

Actively Recruiting

13

University of Wisconsin ( Site 1210)

Madison, Wisconsin, United States, 53792

Actively Recruiting

14

Westmead Hospital ( Site 0100)

Sydney, New South Wales, Australia, 2145

Actively Recruiting

15

Alfred Health ( Site 0102)

Melbourne, Victoria, Australia, 3004

Actively Recruiting

16

Austin Health ( Site 0103)

Melbourne, Victoria, Australia, 3084

Actively Recruiting

17

One Clinical Research ( Site 0104)

Mount Pleasant, Western Australia, Australia, 6009

Actively Recruiting

18

QEII Health Sciences Centre - Victoria General Site ( Site 0200)

Halifax, Nova Scotia, Canada, B3H 2Y9

Actively Recruiting

19

Sunnybrook Research Institute - Odette Cancer Centre ( Site 0206)

Toronto, Ontario, Canada, M4N 3M5

Actively Recruiting

20

McGill University Health Centre ( Site 0202)

Montreal, Quebec, Canada, H4A 3J1

Actively Recruiting

21

Fundacion Arturo Lopez Perez ( Site 0301)

Santiago, Region M. de Santiago, Chile, 7500921

Actively Recruiting

22

Centro de Oncología de Precisión ( Site 0305)

Santiago, Region M. de Santiago, Chile, 7560908

Actively Recruiting

23

Clínica UC San Carlos de Apoquindo ( Site 0302)

Santiago, Region M. de Santiago, Chile, 7620002

Actively Recruiting

24

Bradfordhill ( Site 0300)

Santiago, Region M. de Santiago, Chile, 8420383

Actively Recruiting

25

The First Affiliated Hospital of Anhui Medical University ( Site 0405)

Hefei, Anhui, China, 230088

Actively Recruiting

26

Fujian Provincial Cancer Hospital ( Site 0408)

Fuzhou, Fujian, China, 350014

Actively Recruiting

27

Zhongshan Hospital Fudan University (Xiamen Branch) ( Site 0412)

Xiamen, Fujian, China, 361015

Actively Recruiting

28

Southern Medical University Nanfang Hospital ( Site 0413)

Fuzhou, Guangdong, China, 510515

Actively Recruiting

29

The First Affiliated Hospital, Sun Yat-sen University ( Site 0404)

Guangzhou, Guangdong, China, 510080

Actively Recruiting

30

Affiliated Cancer Hospital of Guangxi Medical University ( Site 0411)

Nanning, Guangxi, China, 530201

Actively Recruiting

31

Henan Cancer Hospital ( Site 0403)

Zhengzhou, Henan, China, 450008

Actively Recruiting

32

Zhongshan Hospital,Fudan University ( Site 0400)

Shanghai, Shanghai Municipality, China, 200032

Actively Recruiting

33

First Hospital of Shanxi Medical University ( Site 0409)

Taiyuan, Shanxi, China, 030001

Actively Recruiting

34

Hopital de la Croix Rousse ( Site 0502)

Lyon, Auvergne-Rhône-Alpes, France, 69004

Actively Recruiting

35

Hopital Beaujon ( Site 0500)

Clichy, Hauts-de-Seine, France, 92110

Actively Recruiting

36

Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer ( Site 0501)

Rennes, Ille-et-Vilaine, France, 35042

Actively Recruiting

37

Rambam Health Care Campus ( Site 0603)

Haifa, Israel, 3109601

Actively Recruiting

38

Hadassah Medical Center ( Site 0602)

Jerusalem, Israel, 9112001

Actively Recruiting

39

Sourasky Medical Center ( Site 0601)

Tel Aviv, Israel, 6423906

Actively Recruiting

40

Fondazione IRCCS Istituto Nazionale dei Tumori ( Site 0700)

Milan, Italy, 20133

Actively Recruiting

41

ASST Grande Ospedale Metropolitano Niguarda ( Site 0701)

Milan, Italy, 20162

Actively Recruiting

42

Fondazione Policlinico Universitario Agostino Gemelli ( Site 0702)

Roma, Italy, 00168

Actively Recruiting

43

Harbour Cancer & Wellness ( Site 0800)

Auckland, New Zealand, 1023

Actively Recruiting

44

Seoul National University Hospital ( Site 0900)

Seodaemun-gu, Seoul, South Korea, 03080

Actively Recruiting

45

Severance Hospital, Yonsei University Health System ( Site 0903)

Seoul, South Korea, 03722

Actively Recruiting

46

Asan Medical Center ( Site 0902)

Seoul, South Korea, 05505

Actively Recruiting

47

Samsung Medical Center ( Site 0901)

Seoul, South Korea, 06351

Actively Recruiting

48

Hospital Central de Asturias ( Site 1001)

Oviedo, Principality of Asturias, Spain, 33011

Actively Recruiting

49

Hospital Universitari Vall d'Hebron ( Site 1000)

Barcelona, Spain, 08035

Actively Recruiting

50

Hospital Universitario Gregorio Maranon ( Site 1002)

Madrid, Spain, 28007

Actively Recruiting

51

Hospital Clinico San Carlos... ( Site 1003)

Madrid, Spain, 28040

Actively Recruiting

52

Hopitaux Universitaires de Geneve HUG. ( Site 1102)

Geneva, Switzerland, 1211

Actively Recruiting

53

Universitaetsspital Zuerich ( Site 1105)

Zurich, Switzerland, 8091

Actively Recruiting

54

National Cheng Kung University Hospital-Clinical Trial Center ( Site 1502)

Tainan, Taiwan, 704

Actively Recruiting

55

National Taiwan University Hospital ( Site 1500)

Taipei, Taiwan, 10002

Actively Recruiting

56

Taipei Veterans General Hospital ( Site 1501)

Taipei, Taiwan, 112201

Actively Recruiting

57

Faculty of Medicine Siriraj Hospital ( Site 1301)

Bangkoknoi, Bangkok, Thailand, 10700

Actively Recruiting

58

Ramathibodi Hospital ( Site 1302)

Ratchathewi, Bangkok, Thailand, 10400

Actively Recruiting

59

Dr. Abdurrahman Yurtaslan Ankara Onkoloji Egitim ve Arastırma Hastanesi ( Site 1400)

Yenimahalle, Ankara, Turkey (Türkiye), 06200

Actively Recruiting

60

Dokuz Eylul Universitesi Hastanesi ( Site 1402)

Balçova, İzmir, Turkey (Türkiye), 35340

Actively Recruiting

61

Adana City Hospital ( Site 1404)

Adana, Turkey (Türkiye), 01370

Active, Not Recruiting

62

Hacettepe Universite Hastaneleri ( Site 1401)

Ankara, Turkey (Türkiye), 06230

Active, Not Recruiting

Loading map...

Research Team

T

Toll Free Number

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here